FDA to Discuss Autism and Available Treatments in May

An upcoming public meeting is intended to allow the US Food and Drug Administration (FDA) to obtain patient perspectives on the impact of autism on daily life, as well as views on treatment approaches. As part of commitments tied to the fifth … …read more

Leave a Reply

%d bloggers like this: